NMB

NMB encodes neuromedin B, a neuropeptide that signals through G-protein-coupled receptors (NMBR, NPSR1) to activate phospholipase C/Ca²⁺, ERK1/2, NF-κB, and Wnt pathways, functioning in itch sensation, neuroinflammation, and cancer cell proliferation (PMID:34919054, PMID:36095918, PMID:42029557). NMB-R undergoes rapid agonist-induced internalization and recycling-dependent resensitization, providing a mechanism for signal attenuation (PMID:8163469). In spinal cord neurons, NMB activates Cav3.2 T-type calcium channels to drive IL-1β expression and neuroinflammation, and NMB itself is negatively regulated by miR-214-3p and stabilized by USP21-dependent deubiquitination (PMID:38631219, PMID:40486508). In colorectal cancer, NMB secreted by CD4⁺ T cells activates NPSR1 on malignant cells to trigger Wnt/EMT-driven invasion, which can be antagonized pharmacologically (PMID:42029557).

1. 1994 High

   Establishing how the NMB receptor resets after activation resolved a key question about signal duration: NMB-R desensitizes via internalization and resensitizes by recycling from intracellular stores, independent of new protein synthesis.

   Evidence Radioligand binding, inositol phosphate, and Ca²⁺ assays with monensin/cycloheximide in native C-6 glioblastoma cells and stably transfected Balb/3T3 fibroblasts

   PMID:8163469

   Open questions at the time

   • Molecular identity of kinases and adaptors mediating NMB-R internalization not defined
   • Recycling kinetics not measured in vivo
2. 2010 High

   Determining whether GPNMB/NMB acts in immune evasion revealed that membrane-bound GPNMB on tumor cells directly suppresses T-cell activation through binding syndecan-4, as knockdown eliminated tumor growth only in immunocompetent hosts.

   Evidence siRNA knockdown of Gpnmb in B16F10 cells, syngeneic tumor models in immunocompetent vs. immunodeficient mice, SD-4 blocking experiments

   PMID:20570888

   Open questions at the time

   • Structural basis of GPNMB–syndecan-4 interaction unknown
   • Whether other co-inhibitory ligands compensate for GPNMB loss not tested
3. 2018 High

   Identifying the intracellular signaling requirement for GPNMB's tumorigenic function showed that its hemITAM motif is essential for cancer stem cell induction, as a tyrosine-to-phenylalanine mutant abolished sphere-forming and CSC/EMT gene expression.

   Evidence 3D sphere culture, FACS, mutagenesis (YF mutant), breast tumor transplant model

   PMID:30224376

   Open questions at the time

   • Kinase that phosphorylates the hemITAM in vivo not identified
   • Downstream signaling intermediates between hemITAM and CSC gene expression uncharacterized
4. 2019 Medium

   Defining the extracellular domain requirement showed that the kringle-like domain (KLD) is indispensable for GPNMB's pro-tumorigenic and migratory activities, independent of its subcellular trafficking and homo-oligomerization.

   Evidence KLD deletion mutagenesis with sphere, tumor formation, and migration assays

   PMID:31127873

   Open questions at the time

   • Binding partner(s) recognized by the KLD not identified at this point
   • Whether KLD mediates receptor engagement or acts structurally unknown
5. 2020 High

   Identifying CD44 as the receptor for soluble GPNMB shed by macrophages resolved how paracrine GPNMB promotes metastasis: macrophage-derived GPNMB activates IL-33/IL-1RL1 signaling in cancer cells to drive CSC self-renewal.

   Evidence Gpnmb-mutant DBA/2J mice, CD44 blocking, recombinant IL-33 rescue, in vivo metastasis assay

   PMID:32728200

   Open questions at the time

   • Protease responsible for GPNMB ectodomain shedding not defined
   • Whether IL-33/IL-1RL1 axis is active in all GPNMB-driven tumor types untested
6. 2021 High

   Demonstrating NMB's role in itch neurotransmission showed that BNP facilitates NMB-mediated histaminergic itch through NPRC-NMBR cross-signaling via Gq-coupled PLCβ-Ca²⁺ in spinal cord neurons.

   Evidence Knockout mouse behavioral assays, calcium imaging in NMBR/NPRC co-expressing HEK293 cells, intrathecal injections

   PMID:34919054

   Open questions at the time

   • Whether NPRC-NMBR cross-talk occurs in human spinal cord not verified
   • Downstream transcriptional consequences of this itch circuit not mapped
7. 2021 Medium

   Defining NMB-NMBR signaling in cancer proliferation showed that NMBR engagement activates ERK1/2 and NF-κB/p65 in cervical cancer cells, promoting proliferation and TNF-α expression, reversible by the NMBR antagonist PD168368.

   Evidence Pharmacological inhibition (PD168368), Western blot pathway analysis, proliferation and apoptosis assays

   PMID:36095918

   Open questions at the time

   • Whether NMB acts as autocrine or paracrine ligand in cervical cancer not resolved
   • In vivo therapeutic efficacy of NMBR blockade not tested
8. 2024 Medium

   Linking NMB to neuroinflammation in spinal cord ischemia-reperfusion injury established the miR-214-3p → NMB → Cav3.2 → IL-1β axis, with miR-214-3p directly repressing NMB and NMB activating T-type calcium channels to drive IL-1β.

   Evidence Dual-luciferase reporter assay, Cav3.2-siRNA, intrathecal PD168368, rat spinal cord ischemia-reperfusion model

   PMID:38631219

   Open questions at the time

   • Whether Cav3.2 activation by NMB is direct or mediated through intermediate effectors unknown
   • Relevance of this pathway in human spinal cord injury not demonstrated
9. 2025 Medium

   Identifying GPNMB–CD44 signaling through PYK2/RSK2 in glioblastoma defined how tumor-associated macrophage-secreted GPNMB promotes glioblastoma stem cell glycolytic metabolism and self-renewal.

   Evidence Co-culture, Co-IP, in vivo GBM mouse models, PYK2/RSK2 signaling analysis

   PMID:40626360

   Open questions at the time

   • Whether PYK2/RSK2 and IL-33/IL-1RL1 represent parallel or sequential arms of CD44 signaling unresolved
   • How GPNMB promotes glycolytic reprogramming at the metabolic enzyme level not mapped
10. 2025 Medium

    Demonstrating USP21-dependent deubiquitination of NMB protein in colorectal cancer revealed a post-translational mechanism stabilizing NMB to activate NF-κB-driven tumor progression.

    Evidence Co-immunoprecipitation, Western blot, proliferation/migration/invasion assays in CRC cells

    PMID:40486508

    Open questions at the time

    • Ubiquitin chain linkage type on NMB not characterized
    • E3 ligase targeting NMB for degradation not identified
11. 2025 Medium

    Identifying NMB as a paracrine signal from CD4⁺ T cells that activates NPSR1 on colorectal cancer cells to trigger Wnt/EMT expanded the receptor repertoire of NMB beyond NMBR and linked it to liver metastasis.

    Evidence Single-cell RNA-seq, SHA68 (NPSR1 inhibitor) + anti-PD1 in mouse CRC metastasis models

    PMID:42029557

    Open questions at the time

    • NMB–NPSR1 binding affinity and specificity not biochemically validated
    • Whether NMB–NPSR1 interaction is direct or involves co-receptors unknown

• A unified structural and signaling model integrating NMB's engagement of NMBR, NPSR1, and the GPNMB ectodomain's engagement of CD44/syndecan-4 — including the relative contributions of autocrine versus paracrine signaling — remains to be established.
• No crystal or cryo-EM structure of NMB–receptor complexes available
• Tissue-specific proteolytic processing and post-translational regulation of NMB are incompletely defined
• Quantitative in vivo contribution of NMB versus GRP in overlapping receptor systems not delineated